Rahsaan Thompson sold $475K of ZVRA stock

Rahsaan Thompson, Chief Legal & Compliance of Zevra Therapeutics, Inc. (ZVRA), sold 42,666 shares of ZVRA stock worth $475K, per an SEC Form 4 filed Aug 17, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on Aug 14, 2026, 3 days before it was made public.

ZVRA has moved -1.4% since the trade date, from $11.32 to $11.16 (Nov 12, 2026 close).